Faculty

David T. Rubin, MD, FACG, AGAF, FACP, FASGE Joseph B. Kirsner Professor of Medicine Section Chief, Gastroenterology, Hepatology and Nutrition Co-Director, Digestive Diseases Center University of Chicago Medicine Chicago, IL

Statement of Need

We don't have to tell you that managing your ulcerative colitis (UC) is challenging. At times it seems like you need to be a physician yourself in order to understand the data and the decisions that are best for you. Practice guidelines are designed for gastroenterologists and their care teams; however, knowledge about how the guidelines are developed and how they apply to the individual are important for understanding your doctor's decisions in managing your UC.

Dr. Rubin has you covered! In this live and on-demand webcast, Dr. Rubin will share his insights and take your LIVE questions to help you manage your disease and take back control of your UC.

What you will learn:

At the end of this activity, participants should be able to:

• Recognize the importance of practice guidelines and how they apply to UC.
• Establish long-term treatment goals to heal the inflamed bowels instead of masking the symptoms.
• Identify key markers of inflammation in inflammatory bowel disease and how they are used in practice.
• Evaluate the risk of colorectal cancer and colostomy in UC.
• Engage with your UC doctor to discuss your disease and strategies to establish and maintain clinical remission.

Financial Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

Individuals with ulcerative colitis

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Rubin reports that he receives grants from AbbVie Inc.; Genentech, Inc./Roche; Janssen Pharmaceuticals, Inc.; Prometheus Laboratories Inc.; Shire; and Takeda Pharmaceuticals U.S.A., Inc. He is a consultant for AbbVie Inc.; AbGenomics; Allergan; Arena Pharmaceuticals, Inc.; Biomica; Bristol-Myers Squibb Company; Dizal Pharmaceutical; Eli Lilly and Company; Ferring Pharmaceuticals Inc.; Genentech, Inc./Roche; Janssen Pharmaceuticals, Inc.; Medtronic; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Pfizer Inc.; Shire; Takeda Pharmaceuticals U.S.A., Inc.; and TARGET PharmaSolutions, Inc. He receives other financial or material support as a member of the Board of Trustees for the American College of Gastroenterology; as Co-Founder, CFO of Cornerstones Health, Inc. (non-profit); and as Co-Founder of GoDuRn, LLC.

Olga Askinazi, PhD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS(877.263.7767).

TV-106-110719-20